Chandan Healthcare Ltd
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]
- Market Cap ₹ 582 Cr.
- Current Price ₹ 238
- High / Low ₹ 358 / 185
- Stock P/E 21.8
- Book Value ₹ 68.5
- Dividend Yield 0.00 %
- ROCE 22.8 %
- ROE 19.0 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 102% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -1.19%
- Working capital days have increased from 72.1 days to 152 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of Nifty SME Emerge
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 67 | 56 | 72 | 76 | 100 | 129 | 157 | 167 | |
| Sales growth | -16% | +28% | +6% | +32% | +29% | +21% | ||
| 60 | 51 | 69 | 67 | 74 | 93 | 110 | 116 | |
| Operating Profit | 6 | 5 | 3 | 9 | 25 | 36 | 46 | 51 |
| OPM % | 9% | 9% | 3.8% | 12% | 25% | 28% | 30% | 30% |
| 0 | 0 | 0 | 0 | 1 | 2 | 1 | 2 | |
| Interest | 2 | 2 | 2 | 2 | 2 | 4 | 4 | 7 |
| Depreciation | 2 | 2 | 2 | 2 | 3 | 6 | 10 | 11 |
| Profit before tax | 2 | 1 | -1 | 5 | 21 | 28 | 34 | 34 |
| Tax % | 39% | 45% | 93% | 23% | 24% | 26% | 25% | |
| 1 | 1 | -1 | 4 | 16 | 21 | 25 | 25 | |
| EPS in Rs | 0.71 | 0.41 | -0.68 | 2.02 | 8.01 | 8.50 | 10.36 | 10.13 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 23% |
| 3 Years: | 27% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 102% |
| 3 Years: | 89% |
| TTM: | 32% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 25% |
| Last Year: | 19% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 20 | 20 | 20 | 20 | 20 | 24 | 24 |
| Reserves | 4 | 5 | 3 | 7 | 21 | 96 | 143 |
| 15 | 14 | 15 | 17 | 29 | 33 | 39 | |
| 20 | 18 | 22 | 26 | 23 | 23 | 26 | |
| Total Liabilities | 59 | 56 | 59 | 70 | 93 | 177 | 232 |
| 20 | 20 | 25 | 28 | 44 | 71 | 96 | |
| CWIP | -0 | -0 | -0 | -0 | -0 | 4 | 12 |
| Investments | 20 | 11 | 14 | 15 | 13 | 37 | 24 |
| 19 | 25 | 21 | 27 | 37 | 65 | 101 | |
| Total Assets | 59 | 56 | 59 | 70 | 93 | 177 | 232 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| -7 | 7 | 5 | 6 | 6 | 24 | ||
| 7 | -10 | -2 | -15 | -61 | -50 | ||
| -0 | -2 | -2 | 9 | 60 | 23 | ||
| Net Cash Flow | 0 | -4 | 1 | -1 | 6 | -3 | |
| Free Cash Flow | -7 | 1 | -0 | -13 | -32 | -17 | |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -121% | 274% | 61% | 37% | 38% | 70% |
Ratios
Standalone / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 76 | 53 | 77 | 80 | 88 | 103 |
| Inventory Days | 88 | 78 | 37 | 9 | |||
| Days Payable | 126 | 224 | 233 | 399 | |||
| Cash Conversion Cycle | 15 | -69 | -143 | -314 | 80 | 88 | 103 |
| Working Capital Days | -66 | -10 | -60 | -67 | -14 | 78 | 152 |
| ROCE % | 9% | 2% | 18% | 41% | 28% | 23% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Number of Collection Centers count |
|
||||
| Number of Diagnostic Centers & Labs count |
|||||
| Pathology Revenue Share % |
|||||
| Total Tests Conducted Lakhs |
|||||
| B2C (Retail Diagnostics) Revenue Share % |
|||||
| B2G (Government PPPs) Revenue Share % |
|||||
| Total Patient Count Lakhs |
|||||
| Number of Franchise Centers count |
|||||
Extracted by Screener AI
Documents
Announcements
-
Monitoring Agency Report
- Monitoring agency report for Q2 FY27 shows preferential issue proceeds used as planned, with no major deviation.
-
Copy of Newspaper Publication
- Published EGM notice in Financial Express and Jansatta; EGM on 20 November 2026 via VC/OAVM.
-
Copy of Newspaper Publication
- Chandan Healthcare Limited has informed about Copy of Newspaper Publication
-
Shareholders meeting
- EGM on 20 Nov 2026 to approve related-party transactions and personal guarantees up to Rs.85 crore each.
-
General Updates
- Q2 FY27 diagnostics revenue rose 46.66%; 410 franchises added, total 685.
Concalls
-
Aug 2026Transcript PPT REC
-
Jun 2026Transcript PPT REC
-
Feb 2026Transcript PPT
-
Dec 2025Transcript PPT
-
Nov 2025PPT REC
-
Aug 2025PPT
Business Profile[1]
Chandan Healthcare Limited operates a diagnostic network in North India that offers pathology and radiology testing services. The company has a presence in Uttar Pradesh, Uttarakhand, and Jaipur (Rajasthan), with a strong network of labs, satellite centers, and collection points.